Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP856821.RAJtzbIwGNJT-WNu11nKnbRW_SgrSMxeQ7PyEBrb2C5UI130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP856821.RAJtzbIwGNJT-WNu11nKnbRW_SgrSMxeQ7PyEBrb2C5UI130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP856821.RAJtzbIwGNJT-WNu11nKnbRW_SgrSMxeQ7PyEBrb2C5UI130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP856821.RAJtzbIwGNJT-WNu11nKnbRW_SgrSMxeQ7PyEBrb2C5UI130_provenance.
- NP856821.RAJtzbIwGNJT-WNu11nKnbRW_SgrSMxeQ7PyEBrb2C5UI130_assertion description "[Up till now EGFR gene mutations, KRAS gene mutations and EML4-ALK fusion genes are the most widely recognized alterations involved in both the biology and the clinical management of lung adenocarcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP856821.RAJtzbIwGNJT-WNu11nKnbRW_SgrSMxeQ7PyEBrb2C5UI130_provenance.
- NP856821.RAJtzbIwGNJT-WNu11nKnbRW_SgrSMxeQ7PyEBrb2C5UI130_assertion evidence source_evidence_literature NP856821.RAJtzbIwGNJT-WNu11nKnbRW_SgrSMxeQ7PyEBrb2C5UI130_provenance.
- NP856821.RAJtzbIwGNJT-WNu11nKnbRW_SgrSMxeQ7PyEBrb2C5UI130_assertion SIO_000772 21129606 NP856821.RAJtzbIwGNJT-WNu11nKnbRW_SgrSMxeQ7PyEBrb2C5UI130_provenance.
- NP856821.RAJtzbIwGNJT-WNu11nKnbRW_SgrSMxeQ7PyEBrb2C5UI130_assertion wasDerivedFrom befree-2016 NP856821.RAJtzbIwGNJT-WNu11nKnbRW_SgrSMxeQ7PyEBrb2C5UI130_provenance.
- NP856821.RAJtzbIwGNJT-WNu11nKnbRW_SgrSMxeQ7PyEBrb2C5UI130_assertion wasGeneratedBy ECO_0000203 NP856821.RAJtzbIwGNJT-WNu11nKnbRW_SgrSMxeQ7PyEBrb2C5UI130_provenance.
- befree-2016 importedOn "2016-02-19" NP856821.RAJtzbIwGNJT-WNu11nKnbRW_SgrSMxeQ7PyEBrb2C5UI130_provenance.